CLINICAL TRIALS PROFILE FOR FINASTERIDE
✉ Email this page to a colleague
All Clinical Trials for Finasteride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | Cancer and Leukemia Group B | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | Eastern Cooperative Oncology Group | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | National Cancer Institute (NCI) | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | NCIC Clinical Trials Group | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| NCT00002651 ↗ | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | Completed | Southwest Oncology Group | Phase 3 | 1995-05-01 | RATIONALE: Testosterone can stimulate the growth of prostate cancer cells. Hormone therapy may be effective treatment for prostate cancer. It is not yet known which regimen of hormone therapy is most effective for stage IV prostate cancer. PURPOSE: This randomized phase III trial is studying two different regimens of hormone therapy and comparing how well they work in treating men with stage IV prostate cancer. |
| NCT00003323 ↗ | Hormone Therapy in Treating Patients With Prostate Cancer | Completed | National Cancer Institute (NCI) | Phase 2 | 1998-05-01 | RATIONALE: Male hormones can stimulate the growth of prostate cancer cells. Hormone therapy using flutamide and finasteride may fight prostate cancer by reducing the production of male hormones. PURPOSE: Phase II trial to study the effectiveness of flutamide and finasteride in treating prostate cancer patients with high PSA levels who were previously treated with radiation therapy or radical prostatectomy. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Finasteride
Condition Name
Clinical Trial Locations for Finasteride
Trials by Country
Clinical Trial Progress for Finasteride
Clinical Trial Phase
Clinical Trial Sponsors for Finasteride
Sponsor Name
